EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High‐Grade Mucoepidermoid Carcinoma

Kush Panara iD, Neel Sangal, Deepak Lakshmipathy, Karthik Rajasekaran iD

Otolaryngology–Head and Neck Surgery · 2024-07 · 171 (1) · 138-145

DOI: 10.1002/ohn.695 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2024-03. Written by Kush Panara and 3 co-authors. Institution: Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Carcinoma, Mucoepidermoid, Neck Dissection, SEER Program, Elective Surgical Procedures. Cited 7 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

We aim to evaluate the role of elective neck dissection (END) and adjuvant radiation on survival in N0 high‐grade mucoepidermoid carcinoma (MEC). Study Design Retrospective cohort study.

Setting

National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database.

Methods

All patients diagnosed with high‐grade MEC with node‐negative disease (N0) from 2004 to 2018 were included. Demographic, clinicopathologic, treatment, and outcomes were analyzed. Kaplan‐Meier survival curves were used to evaluate 5‐year disease‐specific survival (DSS) and 5‐year overall survival (OS). Multivariate Cox regression analysis was used to control for confounders.

Results

A total of 310 patients with high‐grade MEC and N0 (clinical and pathologic) disease were identified. The parotid was the most common primary site (266, 86%). Of included patients, 133 (42.9%) were T3‐T4 tumors and 212 (68%) received adjuvant radiation. END was performed on 223 (71.9%) of cases. END in T3‐T4 high‐grade MEC led to significant improvements in DSS (74.3% vs 34.0%, P < .01) and OS (55.2% vs 20.5%, P < .01) as compared to no END. Subanalysis shows that in patients who received neck dissections and were pathologic N0, adjuvant radiation had no impact on DSS (84.0% vs 72.1%, P = .45) and OS (52.1% vs 55.8%, P = .91). Benefits persisted when controlling for confounders using multivariate Cox proportional regression.

Conclusion

Patients with T3‐T4 high‐grade MEC who underwent END and found to be pathologically node‐negative (pN0) had significantly improved 5‐year DSS and 5‐year OS than patients who were cN0 and did not undergo END. Importantly, although 68% of patients received adjuvant radiation, we show no benefit of this treatment modality on outcomes in pN0 high‐grade MEC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, MucoepidermoidNeck DissectionSEER ProgramElective Surgical ProceduresHumansMaleFemaleRetrospective StudiesRadiotherapy, AdjuvantMiddle AgedAdultAgedSurvival RateNeoplasm StagingNeoplasm GradingUnited States

Author keywords

adjuvant radiation therapyelective neck dissectionmucoepidermoid cancersalivary gland cancer

Authors and institutions

  • Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: Kush Panara, Karthik Rajasekaran

Cite

APA

Panara, K., Sangal, N., Lakshmipathy, D., & Rajasekaran, K. (2024). Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High‐Grade Mucoepidermoid Carcinoma. Otolaryngology–Head and Neck Surgery, 171(1), 138-145. https://doi.org/10.1002/ohn.695

Vancouver

Panara K, Sangal N, Lakshmipathy D, Rajasekaran K. Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High‐Grade Mucoepidermoid Carcinoma. Otolaryngology–Head and Neck Surgery. 2024;171(1):138-145. doi:10.1002/ohn.695

BibTeX
@article{Panara2024,
  author = {Panara, Kush and Sangal, Neel and Lakshmipathy, Deepak and Rajasekaran, Karthik},
  title = {Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High‐Grade Mucoepidermoid Carcinoma},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  volume = {171},
  number = {1},
  pages = {138--145},
  doi = {10.1002/ohn.695}
}
Start for free →